Literature DB >> 17997340

Impaired cytokine production by peripheral blood mononuclear cells in type 1 diabetic patients.

N T Foss1, M C Foss-Freitas, M A N Ferreira, R N Cardili, C M C Barbosa, M C Foss.   

Abstract

AIMS: The objective of the present investigation was to study the production of IL-1, IL-6, IL-10, IFNgamma and TNFalpha in cultures of peripheral blood mononuclear cells (PBMC) taken from type 1 diabetic patients with inadequate metabolic control.
METHODS: Seventeen type 1 diabetic patients and a gender- and age-matched group of 17 healthy individuals were studied. PBMC cultures were stimulated with phytohemagglutinin (PHA; 20 microg/ml) and lipopolysaccharide (LPS; 10 microg/ml), and enzyme immunoassay (Elisa) was used to measure IL-1, IL-6, IL-10, IFNgamma and TNFalpha in the cell-culture supernatants.
RESULTS: IFNgamma levels in PHA-stimulated cultures were lower in the type 1 diabetics than in the non-diabetic controls (P<0.0001) while, in contrast, IL-10 levels were increased in the PHA-stimulated culture supernatants of the diabetics compared with the controls (P<0.0001). In addition, supernatant levels of the cytokines IL-1, IL-6 and TNFalpha released in the presence of LPS in the cell cultures from the diabetic patients were significantly lower than in the non-diabetic subjects (P<0.0001, P<0.0001 and P<0.03, respectively).
CONCLUSIONS: The impaired production of IL-1, IL-6, TNFalpha and IFNgamma, and the increased production of IL-10, in PBMC cultures from type 1 diabetics with inadequate metabolic control compared with healthy subjects may be an indication of a deficiency in mononuclear cell activation and, consequently, a deficient immune cellular adaptive response that, in turn, may be the cause of the increased incidence of infections in people with type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997340     DOI: 10.1016/j.diabet.2007.10.001

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  12 in total

1.  Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes.

Authors:  Dongmei Han; Carlos A Leyva; Della Matheson; Davide Mineo; Shari Messinger; Bonnie B Blomberg; Ana Hernandez; Luigi F Meneghini; Gloria Allende; Jay S Skyler; Rodolfo Alejandro; Alberto Pugliese; Norma S Kenyon
Journal:  Clin Immunol       Date:  2011-02-24       Impact factor: 3.969

2.  Upregulation of proinflammatory cytokine production in response to bacterial pathogen-associated molecular patterns in dogs with diabetes mellitus undergoing insulin therapy.

Authors:  Amy E DeClue; Jordan Nickell; Chee-hoon Chang; Allison Honaker
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

3.  Oral treatment with Hev b 13 prevents experimental arthritis in mice.

Authors:  Larissa De Bortoli Teixeira; Vera Lúcia Aparecida Aguillar Epifânio; João José Lachat; Norma Tiraboschi Foss; Joaquim Coutinho-Netto
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

4.  Cyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients.

Authors:  Alessandro Baldan; Silvia Ferronato; Silvia Olivato; Giovanni Malerba; Alberto Scuro; Gian Franco Veraldi; Matteo Gelati; Sergio Ferrari; Sara Mariotto; Pier Franco Pignatti; Sara Mazzucco; Macarena Gomez-Lira
Journal:  Inflamm Res       Date:  2014-08-06       Impact factor: 4.575

5.  Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1β in Patients With Type 1 Diabetes.

Authors:  Sharad Purohit; Ashok Sharma; Diane Hopkins; Leigh Steed; Bruce Bode; Stephen W Anderson; John Chip Reed; R Dennis Steed; Tao Yang; Jin-Xiong She
Journal:  J Clin Endocrinol Metab       Date:  2015-07-09       Impact factor: 5.958

6.  Excessive localized leukotriene B4 levels dictate poor skin host defense in diabetic mice.

Authors:  Stephanie L Brandt; Sue Wang; Naiara N Dejani; Nathan Klopfenstein; Seth Winfree; Luciano Filgueiras; Brian P McCarthy; Paul R Territo; C Henrique Serezani
Journal:  JCI Insight       Date:  2018-09-06

7.  Oral supplementation of diabetic mice with propolis restores the proliferation capacity and chemotaxis of B and T lymphocytes towards CCL21 and CXCL12 by modulating the lipid profile, the pro-inflammatory cytokine levels and oxidative stress.

Authors:  Ahmad A Al Ghamdi; Gamal Badr; Wael N Hozzein; Ahmed Allam; Noori S Al-Waili; Mohammed A Al-Wadaan; Olivier Garraud
Journal:  BMC Immunol       Date:  2015-09-15       Impact factor: 3.615

8.  Diet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis.

Authors:  Fazal Shirazi; Dimitrios Farmakiotis; Yuanqing Yan; Nathaniel Albert; Kim-Anh Do; Do Kim-Anh; Dimitrios P Kontoyiannis
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

9.  Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures.

Authors:  Melanie Cebioglu; Hans H Schild; Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-03-11       Impact factor: 6.543

10.  Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children.

Authors:  S Hamari; T Kirveskoski; V Glumoff; P Kulmala; O Simell; M Knip; R Veijola
Journal:  Scand J Immunol       Date:  2016-04       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.